Core Differences in Synaptic Signaling Between Primary Visual and Dorsolateral Prefrontal Cortex.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Oxford University Press Country of Publication: United States NLM ID: 9110718 Publication Model: Print Cited Medium: Internet ISSN: 1460-2199 (Electronic) Linking ISSN: 10473211 NLM ISO Abbreviation: Cereb Cortex Subsets: MEDLINE
    • Publication Information:
      Original Publication: New York, NY : Oxford University Press, c1991-
    • Subject Terms:
    • Abstract:
      Neurons in primary visual cortex (V1) are more resilient than those in dorsolateral prefrontal cortex (dlPFC) in aging, schizophrenia and Alzheimer's disease. The current study compared glutamate and neuromodulatory actions in macaque V1 to those in dlPFC, and found striking regional differences. V1 neuronal firing to visual stimuli depended on AMPA receptors, with subtle NMDA receptor contributions, while dlPFC depends primarily on NMDA receptors. Neuromodulatory actions also differed between regions. In V1, cAMP signaling increased neuronal firing, and the phosphodiesterase PDE4A was positioned to regulate cAMP effects on glutamate release from axons. HCN channels in V1 were classically located on distal dendrites, and enhanced cell firing. These data contrast with dlPFC, where PDE4A and HCN channels are concentrated in thin spines, and cAMP-HCN signaling gates inputs and weakens firing. These regional differences may explain why V1 neurons are more resilient than dlPFC neurons to the challenges of age and disease.
    • References:
      Brain Res. 1992 Dec 25;599(2):283-96. (PMID: 1363285)
      Nat Neurosci. 2007 Mar;10(3):376-84. (PMID: 17277774)
      Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17957-62. (PMID: 19805148)
      Neuron. 1995 Mar;14(3):477-85. (PMID: 7695894)
      Biochem J. 2011 May 1;435(3):755-69. (PMID: 21323643)
      Biophys J. 1999 Sep;77(3):1418-27. (PMID: 10465753)
      J Neurophysiol. 2009 Jan;101(1):129-40. (PMID: 18971302)
      Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):E214-9. (PMID: 25540412)
      Biol Psychiatry. 2015 Dec 15;78(12):860-70. (PMID: 25731884)
      Cereb Cortex. 2015 Jun;25(6):1454-68. (PMID: 24323499)
      Nat Commun. 2017 Jan 05;8:13804. (PMID: 28054544)
      Curr Neurovasc Res. 2013 Feb;10(1):70-5. (PMID: 23151080)
      Neuron. 2007 Nov 21;56(4):701-13. (PMID: 18031686)
      Prog Neurobiol. 2014 Jan;112:1-23. (PMID: 24184323)
      Curr Neurovasc Res. 2009 May;6(2):104-9. (PMID: 19442159)
      Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16791-6. (PMID: 18922773)
      J Physiol. 2000 Jul 1;526 Pt 1:91-7. (PMID: 10878102)
      Neuron. 2013 Feb 20;77(4):736-49. (PMID: 23439125)
      Neuron. 2013 May 22;78(4):729-39. (PMID: 23719166)
      J Neurosci. 2002 Apr 15;22(8):3189-205. (PMID: 11943820)
      Neuroscience. 2014 Aug 22;274:33-43. (PMID: 24853052)
      J Neurophysiol. 2012 Jan;107(1):283-91. (PMID: 21994270)
      Neurobiol Aging. 1995 May-Jun;16(3):271-8; discussion 278-84. (PMID: 7566337)
      Neuron. 2012 Oct 4;76(1):223-39. (PMID: 23040817)
      J Physiol Paris. 2016 Sep;110(1-2):44-51. (PMID: 27619519)
      Cereb Cortex. 2013 Jul;23(7):1643-54. (PMID: 22693343)
      Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):12078-83. (PMID: 23818597)
      Eur J Neurosci. 1999 Dec;11(12):4320-6. (PMID: 10594657)
      Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):5036-41. (PMID: 24707050)
      Nat Neurosci. 2015 Oct;18(10):1376-85. (PMID: 26404712)
      Neuron. 1999 Oct;24(2):377-87. (PMID: 10571231)
      Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1645-50. (PMID: 11818532)
      Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):11031-6. (PMID: 22615394)
      Nat Neurosci. 2005 Nov;8(11):1542-51. (PMID: 16234810)
      J Neurophysiol. 2005 Dec;94(6):3872-83. (PMID: 16093340)
      J Neurophysiol. 2003 Aug;90(2):771-9. (PMID: 12672778)
      Nature. 2011 Jul 27;476(7359):210-3. (PMID: 21796118)
      J Neurosci. 1987 Jun;7(6):1799-808. (PMID: 2439665)
      Neuropsychopharmacology. 2006 Mar;31(3):516-24. (PMID: 16123769)
      J Neurophysiol. 1989 Feb;61(2):331-49. (PMID: 2918358)
      Front Syst Neurosci. 2015 May 27;9:82. (PMID: 26074788)
      J Neurosci. 1998 Mar 15;18(6):2108-17. (PMID: 9482797)
      Trends Neurosci. 2003 Jul;26(7):369-78. (PMID: 12850433)
      Neurobiol Stress. 2015;2:1-9. (PMID: 25664335)
      Nature. 2008 Aug 28;454(7208):1110-4. (PMID: 18633352)
      Semin Cell Biol. 1994 Aug;5(4):211-9. (PMID: 7994005)
      Arch Gen Psychiatry. 2000 Jan;57(1):65-73. (PMID: 10632234)
      Curr Opin Neurobiol. 2007 Jun;17(3):381-6. (PMID: 17498943)
      Nat Neurosci. 2002 Nov;5(11):1185-93. (PMID: 12389030)
      J Neurosci. 1999 Nov 1;19(21):9587-603. (PMID: 10531461)
      Cell. 2007 Apr 20;129(2):397-410. (PMID: 17448997)
      J Pharmacol Exp Ther. 1997 Dec;283(3):1285-92. (PMID: 9400004)
      J Neurosci. 2004 Oct 6;24(40):8885-95. (PMID: 15470155)
      Science. 1991 Sep 6;253(5024):1135-8. (PMID: 1716001)
      Neuron. 2004 Feb 5;41(3):417-29. (PMID: 14766180)
    • Grant Information:
      DP1 AG047744 United States AG NIA NIH HHS; R01 EY025103 United States EY NEI NIH HHS
    • Accession Number:
      0 (Cardiovascular Agents)
      0 (Excitatory Amino Acid Antagonists)
      0 (Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels)
      0 (Pyrimidines)
      133059-99-1 (ICI D2788)
      23583-48-4 (8-Bromo Cyclic Adenosine Monophosphate)
      EC 3.1.4.17 (Cyclic Nucleotide Phosphodiesterases, Type 4)
      EC 3.1.4.17 (PDE4A protein, human)
    • Publication Date:
      Date Created: 20180120 Date Completed: 20190626 Latest Revision: 20191008
    • Publication Date:
      20231215
    • Accession Number:
      PMC6041807
    • Accession Number:
      10.1093/cercor/bhx357
    • Accession Number:
      29351585